Sanofi (SNY.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Trending

Earning Release Date

FY2025 Q4 Earning Release 2026.01.28 (EST)

Event Tracking

Dec24

Sanofi's Tolizumab NDA Receives FDA Complete Response Letter

06:21

Sanofi to Acquire Dynavax

06:17

Dec19

Sanofi Cuts Drug Prices and Plans to Upgrade Facilities in the US

19:23

Trump and multiple drug companies announce price cuts

17:45

Luisa Hector Maintains Buy Rating on Sanofi

08:12

Dec17

Sanofi's Aficamten Receives Marketing Approval in China

13:16

Schedules & Filings

Schedules

Filings

Jan29

Earning Release(EST)

FY2025 Q4 Earning Release

Oct24

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 15.45 B, Net Income 3.286 B, EPS 1.3488

Jul31

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 12.57 B, Net Income 4.612 B, EPS 1.8946

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More